In vitro biomarker discovery for atherosclerosis by proteomics (Q40501649)

21 September 2017

In vitro biomarker discovery for atherosclerosis by proteomics (English)

1 reference

21 September 2017

0 references

1 reference

Estelle M Fach

1

1 reference

21 September 2017

Leah-Ann Garulacan

2

1 reference

21 September 2017

Ji Gao

3

1 reference

21 September 2017

Qing Xiao

4

1 reference

21 September 2017

Stephen M Storm

5

1 reference

21 September 2017

Yves P Dubaquie

6

1 reference

21 September 2017

Stanley A Hefta

7

1 reference

21 September 2017

Gregory J Opiteck

8

1 reference

21 September 2017

20 October 2004

1 reference

Molecular & Cellular Proteomics

21 September 2017

1 reference

21 September 2017

3

1 reference

21 September 2017

1200-1210

1 reference

21 September 2017

12

1 reference

Biologic aspects of vulnerable plaque

21 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Atherosclerotic plaque formation and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Inflammation and atherosclerosis: role of C-reactive protein in risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from human peripheral monocytes and the THP-1 monocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Large scale gene expression analysis of cholesterol-loaded macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Pathophysiology of plaque instability: insights at the genomic level

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Selecting and validating biologic markers for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Identification of in vitro protein biomarkers of idiosyncratic liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Changes in the protein expression of yeast as a function of carbon source

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Serum chitotriosidase activity is increased in subjects with atherosclerosis disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Apoptotic death of inflammatory cells in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400160-MCP200

10.1074/MCP.M400160-MCP200

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference